Browsing by Author Vanrenterghem, Yves

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 10 of 10
Issue DateTitleAuthor(s)
1-Sep-20113-Year Safety Profile of Belatacept in Kidney Transplant Recipients from the BENEFIT and BENEFIT-EXT StudiesCharpentier, Bernard; Grinyo, Josep; Pestana, Jose Osmar Medina [UNIFESP]; Vanrenterghem, Yves; Vincenti, Flavio; Dong, Yuping; Thomas, Dolca; Larsen, Christian P.; Hop Bicetre; Univ Hosp Bellvitge; Universidade Federal de São Paulo (UNIFESP); Univ Hosp Leuven; UCSF Kidney Transplant Serv; Bristol Myers Squibb Co; Emory Univ
15-May-2011Belatacept-Based Regimens Are Associated With Improved Cardiovascular and Metabolic Risk Factors Compared With Cyclosporine in Kidney Transplant Recipients (BENEFIT and BENEFIT-EXT Studies)Vanrenterghem, Yves; Bresnahan, Barbara; Campistol, Josep; Durrbach, Antoine; Grinyo, Josep; Neumayer, Hans-Hellmut; Lang, Philippe; Larsen, Christian P.; Mancilla-Urrea, Eduardo; Pestana, Jose Medina [UNIFESP]; Block, Alan; Duan, Tao; Glicklich, Alan; Gujrathi, Sheila; Vincenti, Flavio; Univ Hosp Leuven; Med Coll Wisconsin; Univ Barcelona; Univ Paris 11; Univ Hosp Bellvitge; Univ Med; Hosp Henri Mondor; Emory Univ; Inst Nacl Cardiol Dr Ignacio Chavez; Universidade Federal de São Paulo (UNIFESP); Bristol Myers Squibb Co; Univ Calif San Francisco
27-Dec-2010Belatacept-Based Regimens Versus a Cyclosporine A-Based Regimen in Kidney Transplant Recipients: 2-Year Results From the BENEFIT and BENEFIT-EXT StudiesLarsen, Christian P.; Grinyo, Josep; Medina-Pestana, Jose [UNIFESP]; Vanrenterghem, Yves; Vincenti, Flavio; Breshahan, Barbara; Campistol, Josep M.; Florman, Sander; del Carmen Rial, Maria; Kamar, Nassim; Block, Alan; Di Russo, Gregory; Lin, Chen-Sheng; Garg, Pushkal; Charpentier, Bernard; Emory Univ; Univ Hosp Bellvitge; Universidade Federal de São Paulo (UNIFESP); Univ Hosp Leuven; Univ Calif San Francisco; Med Coll Wisconsin; Univ Barcelona; Mt Sinai Med Ctr; Inst Nefrol; CHU Rangueil; Bristol Myers Squibb Co; Univ Paris S 11
27-Dec-2010An Integrated Safety Profile Analysis of Belatacept in Kidney Transplant RecipientsGrinyo, Josep; Charpentier, Bernard; Pestana, Jose Medina [UNIFESP]; Vanrenterghem, Yves; Vincenti, Flavio; Reyes-Acevedo, Rafael; Apanovitch, Anne Marie; Gujrathi, Sheila; Agarwal, Mamta; Thomas, Dolca; Larsen, Christian P.; Univ Barcelona; Hop Bicetre; Universidade Federal de São Paulo (UNIFESP); Univ Hosp Leuven; Univ Calif San Francisco; Hosp Miguel Hidalgo Aguascalientes; Bristol Myers Squibb Co; Emory Transplant Ctr; Univ Transplant Ctr
1-Aug-2009One year safety profile of belatacept in kidney transplant patients from the benefit and benefit-ext studiesLarsen, Christian; Charpentier, Bernard; Grinyo, Josep M.; Pestana, Jose Osmar Medina [UNIFESP]; Vanrenterghem, Yves; Vincenti, Flavio; Thomas, D.; Di Russo, Gregory B.; Shi, R.; Emory Univ; Hop Bicetre; Univ Hosp Bellvitge; Universidade Federal de São Paulo (UNIFESP); Univ Hosp Kuleuven; Univ Calif San Francisco; Bristol Myers Squibb Co
1-Apr-2010Outcomes as a Function of Donor Criteria from a Phase III Study of Belatacept vs Cyclosporine in Kidney Transplantation (BENEFIT-EXT).Florman, Sander; Durrbach, Antoine; Larsen, Christian; Pestana, Jose Osmar Medina [UNIFESP]; Vanrenterghem, Yves; Vincenti, Flavio; Block, Alan; Garg, Pushkal; Copley, J. Brian; Xing, Jun; Grinyo, Josep; Mt Sinai Med Ctr; Emory Univ; Universidade Federal de São Paulo (UNIFESP); Univ Hosp Leuven; UCSF; Bristol Myers Squibb Co; Univ Hosp Bellvitge
1-Jan-2010Primary Outcomes from a Randomized, Phase III Study of Belatacept Versus Cyclosporine in Kidney Transplant Recipients (BENEFIT Study)Pearson, Thomas; Vincenti, Flavio; Grinyo, Josep; Charpentier, Bernard; Pestana, Jose Osmar Medina [UNIFESP]; Rostaing, Lionel; Vanrenterghem, Yves; Di Russo, Gregory; Garg, Pushkal; Emory Univ; UCSF; Universidade Federal de São Paulo (UNIFESP); Univ Hosp Toulouse; Katholieke Univ Leuven Hosp; Bristol Myers Squibb Co
1-Aug-2009Primary outcomes from a randomized, Phase III study of belatacept vs cyclosporine in ECD kidney transplants (BENEFIT-EXT Study)Durrbach, Antoine; Larsen, Christian P.; Pestana, Jose Osmar Medina [UNIFESP]; Vanrenterghem, Yves; Vincenti, Flavio; Florman, Sander; Block, A. J.; Garg, Pushkal; Sen, K.; Grinyo, Josep M.; Univ Paris 11; Emory Univ; Universidade Federal de São Paulo (UNIFESP); Univ Hosp Kuleuven; Univ Calif San Francisco; Tulane Univ Med Ctr Hosp & Clin; Univ Hosp Bellvitge; Bristol Myers Squibb Co
1-Aug-2009Primary Outcomes from a Randomized, Phase III Study of Belatacept vs Cyclosporine in Kidney Transplant Recipients (BENEFIT Study)Vincenti, Flavio; Grinyo, Josep M.; Charpentier, Bernard; Pestana, Jose Osmar Medina [UNIFESP]; Rostaing, Lionel; Vanrenterghem, Yves; Di Russo, Gregory B.; Garg, Pushkal; Lin, Chen-Sheng; Larsen, Christian; Univ Calif San Francisco; Univ Hosp Bellvitge; Hop Bicetre; Universidade Federal de São Paulo (UNIFESP); CHU Rangueil; Univ Hosp Kuleuven; Bristol Myers Squibb Co; Emory Univ
20-Dec-2007Reduced exposure to calcineurin inhibitors in renal transplantationEkberg, Henrik; Tedesco-Silva, Helio; Demirbas, Alper; Vitko, Stefan; Nashan, Bjorn; Guerkan, Alp; Margreiter, Raimund; Hugo, Christian; Grinyo, Josep M.; Frei, Ulrich; Vanrenterghem, Yves; Daloze, Pierre; Halloran, Philip F.; ELITE Symphony Study; Lund Univ; Universidade Federal de São Paulo (UNIFESP); Akdeniz Univ; Inst Klin & Expt Med; Hannover Med Sch; SB Tepecik Hosp; Univ Klin; Univ Hosp; Ciutat Univ Bellvitge; Free Univ Berlin; Katholieke Univ Leuven; CHU Montpellier; Univ Alberta